4investors | Börsen-News | Adhoc- und Unternehmensnews | H&R

DGAP-News: H&R GmbH & Co. KGaA confirms preliminary figures for Q1 2019

Bild und Copyright: H&R.

Bild und Copyright: H&R.

15.05.2019, 08:10:02 (www.4investors.de - in Kooperation mit DGAP - EQS Group):


DGAP-News: H&R GmbH & Co. KGaA / Key word(s): Quarter Results

H&R GmbH & Co. KGaA confirms preliminary figures for Q1 2019
15.05.2019 / 08:10


The issuer is solely responsible for the content of this announcement.
H&R GmbH & Co. KGaA confirms preliminary figures for Q1 2019

- Overall robust start to the year

- EBITDA at EUR 20.1 million

- Outlook for 2019 confirmed

Salzbergen, May 15, 2019 H&R GmbH & Co. KGaA (abbrev.: H&R KGaA; ISIN DE000A2E4T77) has confirmed the preliminary key figures for the start of the year and achieved a consolidated operating income (EBITDA - Consolidated income before tax, other financial income and expenses and depreciation/amortization, impairment and appreciation of fixed assets and property, plant and equipment) of EUR 20.1 million in the first quarter of 2019 (same period of the previous year: EUR 23.7 million). The past quarter also saw an increase in sales revenues to EUR 286.1 million (Q1-2018: EUR 270.9 million).

Overview of the main key figures:

Group key figures in EUR Million
Q1-2019
Q1-2018
Absolute diff.
Sales revenues
286.1
270.9
15.2
Operating income (EBITDA)
20.1
23.7
-3.6
EBIT
9.4
15.4
-6.0
EBT
7.3
13.8
-6.5
Net profit/loss to shareholders
5.1
9.9
-4.8
Consolidated earnings per share (EUR)
0.14
0.27
-0.13
Operating cash flow
43.6
-2.9
46.5
Free cash flow
25.4
-17.3
42.7
 
3/31/2019
12/31/2018
Absolute diff.
Balance sheet total
795.4
730.4
65.0
Group equity
365.4
357.4
8.0
Equity ratio (%)*
45.9
48.9
-3.0
 
 
 
 
Segment key figures in EUR Million
Q1-2019
Q1-2018
Absolute diff.
ChemPharm Refining
 
 
 
Sales revenues
183.6
175.3
8.3
Operating income (EBITDA)
13.4
15.8
-2.4
 
 
 
 
ChemPharm Sales
 
 
 
Sales revenues
93.8
82.1
11.7
Operating income (EBITDA)
7.0
7.4
-0.4
 
 
 
 
Plastics Segment
 
 
 
Sales revenues
11.5
15.2
-3.7
Operating income (EBITDA)
0.1
1.3
-1.2
 
 
 
 
Reconciliation / Others
 
 
 
Sales revenues
-2.8
-1.8
-1.0
Operating income (EBITDA)
-0.4
-0.7
0.3

 

* Change in percentage points.
All segments again made positive contributions to earnings in this quarter. The difference of
EUR -3.6 million compared to EBITDA in the same quarter of the previous year is mainly due to the inconsistent development of sales volumes, revenue and earnings contributions across the entire segments. The refinery business, for example, achieved better prices at comparable volumes, which were not reflected in better results due to the raw material situation. In international business, volumes increased, while customers remained very price-sensitive, so that the segment closed almost at the prior-year level. The plastics business had to stand its ground in an extremely difficult environment, as is generally known, surrounding the automotive business, and thus suffered a significant loss in earnings.

On the basis of current knowledge, we confirm our expectations for the 2019 operating result in the range of EUR 75.0 million to EUR 90.0 million.

For detailed statements on the trends in business performance and earnings, the company refers to the quarterly report for the first quarter of 2019 published today, which is available for download at www.hur.com in the "Investors Relations" section.

Contact information:
H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser
Neuenkirchener Strasse 8, 48499 Salzbergen
Phone.: +49 40 43218-321, Fax: +49 40 43218-390
Email: ties.kaiser@hur.com ; www.hur.comH&R GmbH & Co. KGaA:
H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

Forward-looking statements and forecasts:
This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.












15.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:
English
Company:
H&R GmbH & Co. KGaA

Neuenkirchener Str. 8

48499 Salzbergen


Germany
Phone:
+49 (0)40 43 218 321
Fax:
+49 (0)40 43 218 390
E-mail:
investor.relations@hur.com
Internet:
www.hur.com
ISIN:
DE000A2E4T77
WKN:
A2E4T7
Listed:
Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID:
811161

 
End of News
DGAP News Service




811161  15.05.2019 





Weitere DGAP-News von H&R

15.11.2019 - DGAP-News: H&R GmbH & Co. KGaA: Veröffentlichung der Ergebnis- und Umsatzentwicklung per Q3-2019
22.10.2019 - DGAP-Adhoc: H&R GmbH & Co. KGaA: Vorläufige Geschäftszahlen für das 3. Quartal 2019
15.08.2019 - DGAP-News: H&R GmbH & Co. KGaA bestätigt Geschäftsentwicklung zum 1. Halbjahr 2019
18.07.2019 - DGAP-News: H&R GmbH & Co. KGaA unter den Gewinnern des Ideenwettbewerbs 'Reallabore der Energiewende' des BMWis
16.07.2019 - DGAP-Adhoc: H&R GmbH & Co. KGaA: Vorläufige Geschäftszahlen für das 1. Halbjahr 2019

4investors-News zu H&R

15.08.2019 - H&R schraubt Gewinnerwartungen zurück
16.07.2019 - H&R tritt beim Ausblick auf die Bremse
22.05.2019 - H&R: Unspektakulärer Auftakt
21.03.2019 - H&R: Prognose liegt über dem Konsens
28.02.2019 - H&R: Deutlicher Gewinnrückgang